摘要
目的采用基因工程方法重组并表达颗粒溶素融合蛋白。方法采用逆转录-聚合酶链反应(RT-PCR)克隆颗粒溶素多肽分子的cDNA,经测序证实后定向插入表达载体pET28a(+),并经双酶切电泳鉴定。进而导入大肠杆菌BL21(DE3)plyS中,经异丙基硫代-β-D半乳糖苷(IPTG)诱导后表达重组融合蛋白。结果经聚丙烯酰胺凝胶电泳(SDS-PAGE)、Western印迹法鉴定,在相对分子质量为9000处有明显的条带。结论经重组表达获得颗粒溶素融合蛋白,有助于进一步探讨颗粒溶素与临床疾病的相关性。
Objective Cloning expression of granulysin recombinant fusion protein in E. coli. Methods The cDNA encoding human granulysin was obtained by RT PCR, confirmed by DNA sequencing, subcloned unidirectionally into the bacterial expression plasmid pET28a( + ) and then transformed into E. coilBL21 (DE3) plyS to express the recombinant fusion protein induced by IPTG. Results It was shown that there was a marked band at 9 kilodalton by SDS and Western blotting. Conclusion The granulysin recombinant fusion protein so obtained can be used for study of its relevance with clinical diseases.
出处
《上海医学》
CAS
CSCD
北大核心
2007年第7期527-529,共3页
Shanghai Medical Journal
基金
上海市重点基础研究项目(05JC14052)
上海市青年科技启明星计划资助项目(QMX01423)
关键词
颗粒溶素
重组融合蛋白
免疫印迹
Granulysin
Recombinant fusion protein
Western blotting